CBS News
FDA's plan to boost cheaper copycat drugs could stall at the patent office
While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer, and other diseases, the U.S. patent office is making it harder for the ...
Medical Xpress
FDA's plan to boost biosimilar drugs could stall at the patent office
These officials were thrilled Oct. 29 when FDA Commissioner Marty Makary announced the agency's plan, which he said would halve the time and money needed to get what are called "biosimilar" drugs to ...
The Spokesman-Review
FDA’s plan to boost biosimilar drugs could stall at the patent office
News Nation/World FDA’s plan to boost biosimilar drugs could stall at the patent office Nov. 28, 2025 Updated Sat., Nov. 29, 2025 at 9:37 p.m. Food and Drug Administration (FDA) Commissioner Dr. Marty ...
The Hill
FDA withdraws proposal to require talc-containing cosmetics to test for asbestos
The Trump administration is withdrawing a proposal to require cosmetic companies to test their talc-containing products for asbestos, according to a public notice Tuesday. The Food and Drug ...
Hosted on MSN
America Just Kinda, Sorta Banned Cigarettes
No drug is quite like nicotine. When it hits your bloodstream, you’re sent on a ride of double euphoria: an immediate jolt of adrenaline, like a strong cup of coffee injected directly into your brain, ...
Reuters
US FDA panel to weigh bid to market nicotine pouches as lower-risk than cigarettes
Nov 21 (Reuters) - The U.S. Food and Drug Administration said on Friday that it will convene a panel of experts on January 22, 2026, to review an request by Swedish Match USA, a unit of Philip Morris ...
Tampa Bay Times
Key Florida lawmakers float plan to add accountability to school vouchers
Jeffrey S. Solochek is an education reporter covering K-12 education policy and schools. Reach him at jsolochek@tampabay.com. Anyone can view a sampling of recent comments, but you must be a Times ...
FiercePharma
FDA’s plan to boost biosimilar drugs could stall at the patent office
While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer, and other diseases, the U.S. patent office is making it harder for the ...
AOL
US FDA panel to weigh bid to market nicotine pouches as lower-risk than cigarettes
(Reuters) -The U.S. Food and Drug Administration said on Friday that it will convene a panel of experts on January 22, 2026, to review ‌an request by Swedish Match USA, a unit of Philip Morris ...
Arkansas Democrat-Gazette
White House floats plan to extend credits
WASHINGTON -- The White House is circulating a proposal that would extend subsidies to help consumers pay for coverage under the Affordable Care Act for two more years, as millions of Americans face ...